Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2026 · second_quarter · Q2
FY 2027 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2026 · first_quarter · Q1
Source: Senate LDA
FY 2027 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2025 · fourth_quarter · Q4
FY 2026 Labor, HHS, Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2025 · third_quarter · Q3
FY 2026 Labor, HHS, Education Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2025 · second_quarter · Q2
FY 2026 Labor, HHS, Education Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2025 · first_quarter · Q1
FY 2025 Labor, HHS, Education Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2024 · fourth_quarter · Q4
FY 2025 Labor, HHS, Education Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2024 · third_quarter · Q3
FY 2025 Labor, HHS, Education Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2024 · second_quarter · Q2
FY 2024 Labor, HHS Appropriations Bill and Pandemic and All-Hazards Preparedness Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2024 · first_quarter · Q1
FY 2024 Labor, HHS Appropriations Bill and Pandemic and All-Hazards Preparedness Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2023 · fourth_quarter · Q4
FY 2024 Labor, HHS Appropriations Bill and Pandemic and All-Hazards Preparedness Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2023 · third_quarter · Q3
FY 2024 Labor, HHS Appropriations Bill and Pandemic and All-Hazards Preparedness Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2023 · second_quarter · Q2
FY 2024 Labor, HHS Appropriations Bill and Pandemic and All-Hazards Preparedness Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2023 · first_quarter · Q1
FY 2024 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2022 · fourth_quarter · Q4
FY 2023 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2022 · third_quarter · Q3
FY 2023 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2022 · second_quarter · Q2
FY 2023 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2022 · first_quarter · Q1
FY 2022 and FY 2023 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2021 · fourth_quarter · Q4
FY 2022 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2021 · third_quarter · Q3
FY 2022 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2021 · second_quarter · Q2
FY 2022 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2021 · first_quarter · Q1
FY 2022 Labor, HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2020 · fourth_quarter · Q4
FY 2021 Labor, HHS Appropriations bill
COVID-19 Relief bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2020 · third_quarter · Q3
FY 2021 Labor, HHS Appropriations bill
COVID-19 Relief bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2020 · second_quarter · Q2
Cares Act and COVID-19 Relief bills
FY 2021 Labor, HHS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2017 · second_quarter · Q2
Appropriations for the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2017 · first_quarter · Q1
Appropriations for the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
TEXAS BIOMEDICAL RESEARCH INSTITUTE via DQB INTERNATIONAL
2016 · fourth_quarter · RR
Legislation, including the 21st Century Cures Act, Authorizations and Appropriations, and Executive Branch actions affecting biomedical research.
Legislation, including the 21st Century Cures Act, Authorizations and Appropriations, and Executive Branch actions affecting biomedical research.
Legislation, including the 21st Century Cures Act, Authorizations and Appropriations, and Executive Branch actions affecting biomedical research.
FINMECCANICA via DQB INTERNATIONAL
2012 · first_quarter · Q1
Legislative issues surrounding the C-27J aircraft.
Filing targets: SENATE
FINMECCANICA via DQB INTERNATIONAL
2011 · fourth_quarter · Q4
Legislative issues surrounding the C-27J aircraft
Filing targets: SENATE
FINMECCANICA via DQB INTERNATIONAL
2007 · mid_year · MM
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
FINMECCANICA via DQB INTERNATIONAL
2006 · year_end · YY
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
NOVARTIS AG via DQB INTERNATIONAL
2005 · mid_year · RR
FINMECCANICA via DQB INTERNATIONAL
2005 · mid_year · MM
Monitor U.S. defense budget and policy developments to assist in possible sales to the U.S. Department of Defense, as well as to assist in possible cooperative ventures with U.S. defense companies.
Monitor U.S. defense budget and policy developments to assist in possible sales to the U.S. Department of Defense, as well as to assist in possible cooperative ventures with U.S. defense companies.
Monitor U.S. defense budget and policy developments to assist in possible sales to the U.S. Department of Defense, as well as to assist in possible cooperative ventures with U.S. defense companies.
FINMECCANICA via DQB INTERNATIONAL
2004 · year_end · RR
OTO MELARA via DQB INTERNATIONAL
2004 · year_end · RR
Legislation, including the 21st Century Cures Act, Authorizations and Appropriations, and Executive Branch actions affecting biomedical research.
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
Filing targets: Energy, Dept of
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
MONITOR U.S. GOVERNMENT BUDGET AND POLICY DEVELOPMENTS TO ASSIST IN POSSIBLE SALES TO THE U.S. GOVERNMENT, AS WELL AS TO ASSIST IN POSSIBLE COOPERATIVE VENTURES WITH U.S. COMPANIES.
Filing targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS)
Monitor U.S. defense budget and policy developments to assist in possible sales to the U.S. Department of Defense, as well as to assist in possible cooperative ventures with U.S. defense companies.
Filing targets: Defense, Dept of (DOD)